Alliance Pharmaceuticals Limited, a wholly owned subsidiary of Alliance Pharma, has purchased all the existing rights to obstetric drug Syntometrine from Novartis for $11.5m. The total consideration for acquiring the rights will be funded ...
Tags: Obstetric Drug, Medicine